期刊文献+

冠心病伴发2型糖尿病患者心率变异性分析 被引量:1

Heart rate variability analysis of patients with coronary heart disease and type 2 diabetes
下载PDF
导出
摘要 目的观察冠心病合并2型糖尿病患者自主神经功能状态。方法选择2005~2011年在我院行24h动态心电图检查的冠心病及糖尿病患者各30人,冠心病伴发2型糖尿病者30人,健康体检者40人,由计算机自动测出心率变异性时域各项指标。结果冠心病患者或2型糖尿病患者心率变异性指标均低于健康对照组(P<0.05),冠心病合并2型糖尿病患者心率变异性指标低于单一疾病者(P<0.05)。结论冠心病合并2型糖尿病患者自主神经功能损害较重,发生恶性心血管事件几率较大。 Objective To observe the autonomic nerve activity of patients with coronary heart disease and type 2 diabetes.Methods The observed object include 30 cases with coronary heart disease,30 cases with diabetes,30 cases with coronary heart disease and type 2 diabetes,40 healthy cases.The heart rate variability in time domain indexes were measured automatically By the computer.Results The heart rate variability indexes of cases with coronary heart disease or type 2 diabetes were lower than healthy persons(P〈0.05).The heart rate variability indexes of cases with coronary heart disease and type 2 diabetes were lower than single disease(P〈0.05).Conclusion The autonomic nerve activity damage of patients with coronary heart disease and type 2 diabetes is heavier,the occurrence of cardiovascular events are more likely.
作者 陈序
出处 《西部医学》 2011年第11期2210-2211,共2页 Medical Journal of West China
关键词 冠心病 2型糖尿病 心率变异性 Coronary heart disease Type 2 diabetes Heart rate variability
  • 相关文献

参考文献4

二级参考文献18

共引文献144

同被引文献18

  • 1Zhang XH, Lu ZL, Liu L. Coronary heart disease in China[J]. Heart, 2008, 94(9):1126-1131.
  • 2Moran A, Gu D, Zhao D, et al. Future Cardiovascular Disease in China .. Markov Model and Risk Factor Scenario Projections From the Coronary Heart Disease Policy Model-China[J]. Cire Cardiovasc Qual Outcomes, 2010, 3(3):243-252.
  • 3Miketic JK, Hravnak M, Stilley CS, et al. Factors influencing the outcomes of patients with both coronary artery disease and diabetes enrolled in standard cardiac rehabilitation programs: a literature review[J]. Cardiovasc Nurs, 2011, 26(3)..210-217.
  • 4Berry C, Noble S, Grdgoire JC, et al. Glycaemic status influ- ences the nature and severity of coronary artery disease[J]. Dia- hetologia, 2010,53(4) :652-658.
  • 5Ryddn L, Standl E, Bartnik M, et al. Guidelines on diabetes, pre-diabetes, and cardiovascular diseases; executivesummary. The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European As- sociation for the Study of Diabetes(EASD)[J]. Eur Heart J, 2007, 28(1) :88-136.
  • 6Bartnik M, Ryden L, Malmberg K, et al. Oral glucose toler- ance test is needed for appropriate classification of glucose regu- lation in patients with coronary artery disease: a report from the Euro Heart Survey on Diabetes and the Heart[J]. Heart, 2007, 93(1) :72-77.
  • 7Okosieme OE, Peter R, Usman M, et al. Can admission and fasting glucose reliably identi:y undiagnosed diabetes in patientswith acute coronary syndrome[J]. Diabetes Care, 2008, 31 (10) : 1955-1959.
  • 8Kemp{ K, Filth R, Dinh W, etal. Screening for overt diabetes by oral glucose tolerance test: stratification by fasting blood glu- cose and patients' age improve practicability of guidelines in car- diological routine[J]. International Journal of Cardiology, 2011, 150(2) :201-205.
  • 9Hu DY, Pan CY, Yu JM, etal. The relationship between coro- nary artery disease and abnormal glucose regulation in China: the China Heart Survey[J]. European Heart Journal, 2006, 27 (21) : 2573-2579.
  • 10Yang W, Lu J, Weng J, et al. Prevalence of diabetes among men and women in China[J]. N Engl J Med, 2010, 362(12): 1090-1101.

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部